NEW YORK (GenomeWeb) – Medicinal Genomics and Courtagen have been awarded a Small Business and Innovation Research grant to develop technology to detect toxins from microbiological contamination of medical marijuana, the companies said today.

The Phase I award from the National Institute on Drug Abuse is for approximately $150,000 and will go toward developing immuno-PCR-based tests, Mike Catalano, senior director of marketing for Medicinal Genomics, said in an email.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.